Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi - 1 Oct 2014

Leu Hsieh-Shong, Ye Jung-Jr, Lee Ming-Hsun, Su Lin-Hui, Huang Po-Yen, Wu Tsu-Lan, Huang Ching-Tai

Abstract excerpt

BACKGROUND: The optimal combination ratio of imipenem to colistin methanesulfonate (CMS) against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii (INS-MDRAB) has not been determined in previous studies. To provide an alternative therapeutic option for clinical INS-MDRAB isolates, we investigated whether clinically achievable serum concentrations of CMS in combination with imipenem enhance the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Academic Medical Centers
Share to Acinetobacter baumannii

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Acinetobacter Infections

Share to Colistin

Share to Drug Resistance, Multiple, Bacterial

Share to Drug Synergism

Share to Imipenem

Share to Molecular Typing

Source

Identifiers

PMID: 23834782
DOI: 10.1016/j.jmii.2013.05.007

Genes

INS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.PMID 23834782Read ↗

Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolatesSemantic proximity Read ↗

In vitro activity of antibiotic combinations against multidrug-resistant strains of Acinetobacter baumannii and the effects of their antibiotic resistance determinants.Semantic proximity Read ↗

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsSemantic proximity Read ↗

In vitro Synergistic Activity of Antimicrobial Combinations Against blaKPC and blaNDM-Producing Enterobacterales With blaIMP or mcr GenesSemantic proximity Read ↗

Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.Semantic proximity Read ↗

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> Isolates?Semantic proximity Read ↗

Treatment of Colistin Dependence-Developing Acinetobacter baumannii with Antibiotic Combinations at Subinhibitory Concentrations.Semantic proximity Read ↗

Novel Approach To Optimize Synergistic Carbapenem-Aminoglycoside Combinations against Carbapenem-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.